Anti-Money Laundering (AML): What It Is, Its History, and How It Works
Anti-Money Laundering (AML): What It Is, Its History, and How It Works
Jan 1, 2009
investopedia.com
IDH1/2-Mutated Treatment-Naïve AML
IDH1/2-Mutated Treatment-Naïve AML
Feb 22, 2021
onclive.com
Unmet Needs and Future Perspectives in AML
Unmet Needs and Future Perspectives in AML
Jun 23, 2022
onclive.com
Emerging Treatment Options for AML in 2024
Emerging Treatment Options for AML in 2024
729 viewsMar 4, 2024
vumedi.com
IDH Mutations in AML
IDH Mutations in AML
Jul 20, 2020
onclive.com
Emerging Targeted Agents in AML
Emerging Targeted Agents in AML
Dec 1, 2016
onclive.com
EHA 2024 Insights: AML Highlights - Focus on Menin Inhibitors
EHA 2024 Insights: AML Highlights - Focus on Menin Inhibitors
63 views10 months ago
vumedi.com
Cloud-Based AML Software For Accountants | IRIS Elements
Feb 15, 2021
iris.co.uk
Novel Targets and Biomarkers in AML
Feb 22, 2021
onclive.com
ESMO 2024 Summary: IDH Mutated AML - Diagnostic and Treatment P…
54 views6 months ago
vumedi.com
Prognostic Significance of IDH Mutations in AML
Jan 21, 2021
onclive.com
AML: An Overview of Available FTL3 Inhibitors
Sep 20, 2018
onclive.com
What is New in AML: Risk Classification, Germline Mutations…
231 views11 months ago
vumedi.com
Treatment of AML: Managing the Patient When Transplant Is Not a…
811 viewsApr 18, 2024
vumedi.com
Dr Eisfeld on Updated Guidelines for the Classification of AML
Apr 18, 2023
onclive.com
The Role of IDH Inhibitors for Treatment of AML
Aug 5, 2021
onclive.com
Frontline Treatment Options for Patients With IDH2-Mutated AML
Feb 14, 2023
onclive.com
Improving Outcomes With Current Therapies in AML and Acute Prom…
66 viewsApr 23, 2023
vumedi.com
AML With Myelodysplasia-Related Changes: An Evolving Poor-Risk …
55 viewsJun 17, 2023
vumedi.com
2020 ASCO Update on AML: Are Ivosidenib and Enasidenib Good …
114 viewsJul 27, 2020
vumedi.com
Management of AML: FLT3 Inhibitors and BCL2 Inhibitors
Feb 1, 2021
onclive.com
Frontline Treatment in Patients With IDH-Mutated AML Unfit for Intensi…
Feb 28, 2023
onclive.com
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mu…
Aug 8, 2022
targetedonc.com
A Potential Role for IDH-1 Inhibitor Olutasidenib in Relapsed/Refracto…
Mar 14, 2023
onclive.com
Hematologic Improvements With Ivosidenib Azacitidine Compared t…
Jul 7, 2022
onclive.com
5:56
Treating AML
69.5K viewsNov 27, 2019
YouTubeYou and AML
6:35
Understanding AML
132.7K viewsDec 2, 2019
YouTubeYou and AML
0:56
SmartSearch AML Introduction
4.5K viewsJan 3, 2020
YouTubeSmartSearch
1:27
What Is AML?
22.9K viewsApr 19, 2018
YouTubeLeukemia & Lymphoma Society
12:13
AML Demo 2017
22.4K viewsNov 2, 2017
YouTubePaxata
See more videos
Static thumbnail place holder